Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 11533 | 908 | 40.4 | 75% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 796 | 11443 | DRY POWDER INHALER//MUCOADHESION//JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ORAL DELIVERY | Author keyword | 24 | 20% | 12% | 107 |
| 2 | ORAL INSULIN DELIVERY | Author keyword | 17 | 72% | 1% | 13 |
| 3 | ORAL INSULIN | Author keyword | 17 | 46% | 3% | 27 |
| 4 | ORAL FORMULAT DEV | Address | 9 | 83% | 1% | 5 |
| 5 | BIOSUR E TECHNOL | Address | 9 | 27% | 3% | 28 |
| 6 | ORAL PROTEIN DELIVERY | Author keyword | 8 | 44% | 2% | 14 |
| 7 | COMPLEXATION POLYMERS | Author keyword | 6 | 100% | 0% | 4 |
| 8 | INSULIN COMPLEX | Author keyword | 6 | 100% | 0% | 4 |
| 9 | ORAL PEPTIDE DELIVERY | Author keyword | 5 | 30% | 1% | 13 |
| 10 | BLOOD GLUCOSE REDUCTION | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ORAL DELIVERY | 24 | 20% | 12% | 107 | Search ORAL+DELIVERY | Search ORAL+DELIVERY |
| 2 | ORAL INSULIN DELIVERY | 17 | 72% | 1% | 13 | Search ORAL+INSULIN+DELIVERY | Search ORAL+INSULIN+DELIVERY |
| 3 | ORAL INSULIN | 17 | 46% | 3% | 27 | Search ORAL+INSULIN | Search ORAL+INSULIN |
| 4 | ORAL PROTEIN DELIVERY | 8 | 44% | 2% | 14 | Search ORAL+PROTEIN+DELIVERY | Search ORAL+PROTEIN+DELIVERY |
| 5 | COMPLEXATION POLYMERS | 6 | 100% | 0% | 4 | Search COMPLEXATION+POLYMERS | Search COMPLEXATION+POLYMERS |
| 6 | INSULIN COMPLEX | 6 | 100% | 0% | 4 | Search INSULIN+COMPLEX | Search INSULIN+COMPLEX |
| 7 | ORAL PEPTIDE DELIVERY | 5 | 30% | 1% | 13 | Search ORAL+PEPTIDE+DELIVERY | Search ORAL+PEPTIDE+DELIVERY |
| 8 | BLOOD GLUCOSE REDUCTION | 4 | 75% | 0% | 3 | Search BLOOD+GLUCOSE+REDUCTION | Search BLOOD+GLUCOSE+REDUCTION |
| 9 | BLOOD TOTAL LEUKOCYTE COUNT | 3 | 100% | 0% | 3 | Search BLOOD+TOTAL+LEUKOCYTE+COUNT | Search BLOOD+TOTAL+LEUKOCYTE+COUNT |
| 10 | POLYISOBUTYLCYANOACRYLATE NANOCAPSULES | 3 | 100% | 0% | 3 | Search POLYISOBUTYLCYANOACRYLATE+NANOCAPSULES | Search POLYISOBUTYLCYANOACRYLATE+NANOCAPSULES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GRAFT COPOLYMER NETWORKS | 50 | 84% | 3% | 27 |
| 2 | COMPLEXATION HYDROGELS | 37 | 75% | 3% | 27 |
| 3 | ENTRAPPED INSULIN | 23 | 76% | 2% | 16 |
| 4 | COMPLEXATION POLYMER HYDROGELS | 15 | 71% | 1% | 12 |
| 5 | SOLANUM TUBEROSUM LECTIN | 15 | 73% | 1% | 11 |
| 6 | MUCOUS GLYCOCALYX LAYERS | 13 | 80% | 1% | 8 |
| 7 | ORAL INSULIN DELIVERY | 10 | 30% | 3% | 28 |
| 8 | POLYALKYLCYANOACRYLATE NANOCAPSULES | 9 | 36% | 2% | 20 |
| 9 | INSULIN DELIVERY | 9 | 16% | 6% | 50 |
| 10 | POLYMETHACRYLIC ACID CHITOSAN | 8 | 100% | 1% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Polymeric hydrogels for oral insulin delivery | 2013 | 44 | 88 | 63% |
| A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery | 2011 | 88 | 104 | 39% |
| Nanoparticle strategies for the oral delivery of insulin | 2008 | 52 | 101 | 56% |
| Emerging micro-and nanotechnology based synthetic approaches for insulin delivery | 2014 | 21 | 327 | 20% |
| Oral insulin delivery | 1999 | 183 | 19 | 47% |
| Intestinal absorption of insulin nanoparticles: Contribution of M cells | 2014 | 5 | 120 | 52% |
| Oral delivery of therapeutic proteins and peptides: a review on recent developments | 2013 | 25 | 41 | 37% |
| Lessons learned from the clinical development of oral peptides | 2015 | 1 | 76 | 26% |
| Hydrogels for oral delivery of therapeutic proteins | 2004 | 58 | 27 | 67% |
| An overview of natural polymers for oral insulin delivery | 2012 | 23 | 57 | 51% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ORAL FORMULAT DEV | 9 | 83% | 0.6% | 5 |
| 2 | BIOSUR E TECHNOL | 9 | 27% | 3.1% | 28 |
| 3 | DRUG DELIVERY MOL RECOGNIT S | 3 | 100% | 0.3% | 3 |
| 4 | SUWAGH SUBSIDIARY DRUG DELIVERY SYST | 2 | 67% | 0.2% | 2 |
| 5 | ARTIFICIAL PANCREAS | 2 | 50% | 0.3% | 3 |
| 6 | NSF PROGRAM THER EUT DIAGNOST DEVICES | 2 | 50% | 0.3% | 3 |
| 7 | BIOCARRIER GRP | 1 | 40% | 0.2% | 2 |
| 8 | BIOMED CEBIMED | 1 | 40% | 0.2% | 2 |
| 9 | BIOMAT DRUG DELIVERY S | 1 | 11% | 0.8% | 7 |
| 10 | BIOMAT DRUG DELIVERY BIONANOTECHNOL MOL REC | 1 | 33% | 0.2% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000210660 | HEPARIN CONJUGATE//ORAL HEPARIN//MED UIJEONGBU ST MARYS HOSP |
| 2 | 0.0000184343 | SODIUM CAPRATE//SUPPOSITORY//ABSORPTION ENHANCER |
| 3 | 0.0000174652 | MUCOADHESION//THIOMERS//BUCCAL DELIVERY |
| 4 | 0.0000127857 | N TRIMETHYL CHITOSAN CHLORIDE//CHITOSAN NANOPARTICLES//TRIPOLYPHOSPHATE |
| 5 | 0.0000121368 | M CELL//M CELLS//FOLLICLE ASSOCIATED EPITHELIUM |
| 6 | 0.0000112232 | INHALED INSULIN//PULMONARY ABSORPTION//PULMONARY DELIVERY |
| 7 | 0.0000110624 | NASAL DELIVERY//NASAL DRUG DELIVERY//NASAL ABSORPTION |
| 8 | 0.0000108656 | NANOCAPSULES//LIPID CORE NANOCAPSULES//POLYALKYLCYANOACRYLATE |
| 9 | 0.0000101444 | COLON SPECIFIC DRUG DELIVERY//COLONIC DELIVERY//COLON TARGETING |
| 10 | 0.0000093617 | MULTIVESICULAR LIPOSOMES//MREV//MULTIVESICULAR LIPOSOME |